Requires healthcare platforms to advise and consult with consumers.

This bill requires healthcare platforms in New Jersey to advise and consult with consumers regarding the therapeutic values, hazards, and uses of drugs, biologicals, and devices they send. The law mandates that these platforms provide this information using electronic methods such as email, text messaging, or video calls. It directly affects online services that allow members to obtain discounts on medications or access telemedicine services. The legislation clarifies that these platforms must follow existing pharmacy practice standards when communicating with users about their prescriptions and medical devices.